| 摘要: |
| 多药耐药性是肿瘤治疗的重要障碍。靶向性、协同载药能力等功能使纳米制剂成为克服肿瘤多药耐药的理想载体。本文首先介绍了多药耐药性的主要产生机制,然后着重介绍了基于抑制外排、诱导细胞程序性死亡的多功能纳米制剂,用于逆转肿瘤多药耐药性的研究进展,以期为耐药性肿瘤治疗提供思路和方法。 |
| 关键词: 纳米制剂 肿瘤 多药耐药 |
| DOI:10.13506/j.cnki.jpr.2022.10.008 |
| 基金项目:国家科技重大专项“重大新药创制”项目(No.2017ZX09101001-004) |
|
|
|
| Research progress on nanomedicine overcoming tumor multidrug resistance |
| KUANG Zheng,QIN Chao,YANG Lei,YIN Lifang,HAN Xiaopeng |
| (School of Pharmacy,China Pharmaceutical University,Nanjing 211198,China) |
| Abstract: |
| For cancer treatment, multidrug resistance (MDR) is an important obstacle. The excellent functions of nanomedicine, such as targeting and co-delivery of drugs, make it a good carrier of overcoming MDR. This paper introduces main mechanisms of MDR, focusing on the design of nanomedicine to overcome MDR with the guidance of inhibiting efflux, inducing programmed cell death,and reversing multidrug resistance by targeting tumor micro-environment. This paper provides reference for the treatment of drug-resistant tumors. |
| Key words: Nanomedicine Tumor Multidrug resistance |